Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicergoline in Dysphagia Patients
NCT05551182Phase 3Completed
- Sponsor
- Phramongkutklao College of Medicine and Hospital
- Start
- Jan 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nicergoline in dysphagia (2 arms), sponsored by Phramongkutklao College of Medicine and Hospital. Primary endpoints: Rate of dysphagia improvement at 12 weeks and Relation between MDL level, substanceP and dysphagia improvement at 4 weeks. Started Jan 2023; status: completed.
02
Drugs
nicergoline
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT05551182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551182.